Antigen business acquisition from Vitro Diagnostics
Company: Riot
The claim, verbatim
AspenBio acquired the antigen business from Vitro Diagnostics, Inc. in July 2000
Source (primary)
Riot DEF 14A filed 2005-09-26 (SEC EDGAR, sec_filing)
View cached copy (2026-09-27)Live source ↗
Quote: “the July 2000 sale of the antigen business from Vitro Diagnostics, Inc. to AspenBio”
How we checked this
Checked on September 30, 2026. The cited source supports every part of this claim.
The proxy describes the July 2000 sale of the antigen business from Vitro Diagnostics, Inc. to AspenBio. It also says AspenBio was organized in July 2000 to make that purchase.
Confirmed in the source:
- AspenBio acquired the antigen business from Vitro Diagnostics, Inc.
- The acquisition took place in July 2000
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1167419/000107997305000678/aspenbio_defproxy.txt) in full (93,165 characters, retrieved September 27, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Riot DEF 14A filed 2005-09-26
Quote: “the July 2000 sale of the antigen business from Vitro Diagnostics, Inc. to AspenBio”